The authors thank Dharani Rhamamurthy and Chih-An Chen for their assistance in organizing data for and/or writing aspects of this Intervention white paper and Nevin El Nimri for redrawing the figure.
Supported by the International Myopia Institute. The publication costs of the International Myopia Institute reports were supported by donations from the Brien Holden Vision Institute, Carl Zeiss Vision, Coopervision, Essilor, Alcon, and Vision Impact Institute.
Disclosure: C.F. Wildsoet, P; A. Chia, None; P. Cho, None; J.A. Guggenheim, None; J.R. Polling, None; S. Read, Cylite Pty Ltd. (F), P; P. Sankaridurg, Brien Holden Vision Institute (E), P; S.-M. Saw, P; K. Trier, Theialife (I), P; J.J. Walline, Bausch & Lomb (F), SightGlass (C); P.-C. Wu, None; J.S. Wolffsohn, Alcon (F), Allergan (F), Aston EyeTech (F, I), Atiya Vision (C), Bausch & Lomb (F), BetterVision Ltd (F), British Contact Lens Association (C), CooperVision (F, C), Eaglet Eye (F), European Union (F), Eyebag (F), EMPharma (F), EyeDocs (F), Gelflex (F), Innovate UK (F), Johnson & Johnson Vision Care (F, C, R), Lenstec (F), Medmont (F), Rayner (F), Santen (C, R), Shire (C), Tearlab (F), Théa (F), Optimec (F), University of Houston (C), Visioncare Research (F, C), P